Inserm Transfert, founded in 2000, is the private subsidiary of Inserm, specialized in life sciences technology transfer and collaborative research projects funding. It works under a Public service Delegation Agreement (DSP).
patent families*
number of contracts and licenses*
* For the year 2021
millions of euros invested in Proof of concept
projects detected*
Serving research
The company supports Inserm research units and researchers in the process undertaken to create value from their work. Its actions are part of the translational continuum, from basic and technological research to clinical development, with the aim of creating economic and societal value.
Lys Therapeutics et Inserm Transfert signent un accord de trois ans
Industrial Partnerships March 2022Linkinvax et Inserm Transfert signent un accord de licence mondiale
Industrial Partnerships February 2022Le Canceropôle Provence-Alpes-Côte d’Azur et Inserm Transfert
Institutional Partnerships December 2020Inserm Transfert et PULSALYS signent un accord de partenariat
Institutional Partnerships October 2019Human Health Startup Factory (HHSF) le consortium porté par Inserm
Industrial Partnerships January 2019